Cargando…
Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatment
BACKGROUND: Tumor profiling is increasingly used in advanced cancer patients to define treatment options, especially in refractory cases where no standard treatment is available. Caris Molecular Intelligence (CMI) is a multiplatform tumor profiling service that is comprehensive of next-generation se...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802110/ https://www.ncbi.nlm.nih.gov/pubmed/31641338 http://dx.doi.org/10.1186/s12962-019-0191-6 |